# ICH Q12: Implementation Considerations for FDA-Regulated Products: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/ich-q12-implementation-considerations-for-fda-regulated-products-draft-guidance-for-industry/2c7d4c33-4495-4c29-abb1-22058de23404

> FDA guidance document: ICH Q12: Implementation Considerations for FDA-Regulated Products: Draft Guidance for Industry. Issue date: May 20, 2021. Get complete insights and analysis.

---

## Details

- Title: ICH Q12: Implementation Considerations for FDA-Regulated Products: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2021-05-20
- Comment Close Date: 2021-10-12
- Last Changed: 2021-09-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-0166">FDA-2021-D-0166</a>

## Related Documents

- [Standardization of Data and Documentation Practices for Product Tracing Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/standardization-of-data-and-documentation-practices-for-product-tracing-guidance-for-industry/d58db3d4-b065-42bd-88a6-e18fe6db0a51)
- [Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/postapproval-manufacturing-changes-to-biosimilar-and-interchangeable-biosimilar-products-questions-and-answers/f791f37f-3382-48a9-8fcb-f27046ac94a4)
- [Bridging for Drug-Device and Biologic-Device Combination Products: Draft  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bridging-for-drug-device-and-biologic-device-combination-products-draft-guidance-for-industry/b906c8bd-9549-44b2-903e-95838dcc4ec3)